Deep vein thrombosis
188 results
1 - 100
Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis- Thrombolysis for acute upper extremity deep vein thrombosis
- Treatment of distal deep vein thrombosis
- Pentasaccharides for the treatment of deep vein thrombosis
- Physical methods for preventing deep vein thrombosis in stroke
- Graduated compression stockings for prevention of deep vein thrombosis
- Compression stockings for preventing deep vein thrombosis in airline passengers
- Home versus in‐patient treatment for deep vein thrombosis
- Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy: Cochrane systematic review
- Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Knee length versus thigh length graduated compression stockings for prevention of deep vein thrombosis in postoperative surgical patients: Cochrane systematic review
- Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Angioplasty or stenting for deep venous thrombosis
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
- Surgery for deep venous insufficiency
- Anticoagulants for people hospitalised with COVID‐19
- Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery: Cochrane systematic review
- Interventions for preventing venous thromboembolism following abdominal aortic surgery
- Statins for primary prevention of venous thromboembolism: Cochrane systematic review
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents
- Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement: Cochrane systematic review
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
- Anticoagulants for acute ischaemic stroke
- Heparin for pregnant women with acquired or inherited thrombophilias
- Thrombophilia testing for prevention of recurrent venous thromboembolism
- CHIVA method for the treatment of chronic venous insufficiency
- Anaesthesia for hip fracture surgery in adults
- Antiplatelet agents for the treatment of deep venous thrombosis
- Methods for administering subcutaneous heparin during pregnancy: Cochrane systematic review
- Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
- Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion
- Rutosides for prevention of post-thrombotic syndrome: Cochrane systematic review
- Topical application of tranexamic acid for the reduction of bleeding
- Anticoagulants versus non‐steroidal anti‐inflammatories or placebo for treatment of venous thromboembolism
- Anticoagulation for perioperative thromboprophylaxis in people with cancer
- Thromboprophylaxis for trauma patients
- Vena caval filters for the prevention of pulmonary embolism
- Neuromuscular electrical stimulation for the prevention of venous thromboembolism
- Injection sclerotherapy for varicose veins
- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
- Joint lavage for osteoarthritis of the knee: Cochrane systematic review
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Interventions for varicose veins and leg oedema in pregnancy
- Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
- Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE
- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
- Rutosides for treatment of post-thrombotic syndrome: Cochrane systematic review
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Treatment for femoral pseudoaneurysms
- Preoperative education for hip or knee replacement: Cochrane systematic review
- Prophylactic anticoagulants for non‐hospitalised people with COVID‐19
- Tranexamic acid for reducing mortality in emergency and urgent surgery
- Compression therapy for prevention of post‐thrombotic syndrome
- Statins for the primary prevention of venous thromboembolism
- Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization
- Standard‐ versus extended‐duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients
- Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
- Vascular closure devices for femoral arterial puncture site haemostasis
- Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins: Cochrane systematic review
- Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement: Cochrane systematic review